About Mirador Therapeutics, Inc.
Redefining Immunology and Inflammation with Precision
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Founded
- 2024
- Company type
- Privately Held
- Company profile name
- Mirador Therapeutics
Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company’s Mirador360 TM precision development engine leverages the latest advances in human genetics and cutting-edge data science to rapidly advance new precision medicines for patients living with chronic immune-mediated inflammatory and fibrotic diseases. Launched in 2024, Mirador has raised over $400 million from leading life sciences investors and is based in San Diego, CA.
Business areas
- Health Care
- Biotechnology
- Medical
- Therapeutics
On LinkedIn
- Followers
- 12,189
- People linked to this company
- 96
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.